ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Erythromycin estolate
C52H97NO18S
1056.4 g/mol
APIDanger

ERYTHROMYCIN ESTOLATE

CAS3521-62-8EC222-532-4
Category
API
Compound Class
Ester
Primary Use
Pharmaceutical Raw Material

Erythromycin estolate is a salt form of erythromycin, consisting of the propanoate ester of erythromycin A and dodecyl sulfate. It is an active pharmaceutical ingredient used in the manufacturing of antibiotic medications.

pharmaceutical raw material for antibiotic manufacturingenzyme inhibitor in research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 3521-62-8

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Erythromycin propionate

CAS134-36-1

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.88

Erythromycin ethylsuccinate

CAS1264-62-6

pharmaceutical raw material

ReferenceSame Category

Ipriflavone

CAS35212-22-7

pharmaceutical raw material

ReferenceSame Category

Iron(III) citrate

CAS3522-50-7

pharmaceutical raw material

ReferenceSame Category

Imeglimin (hydrochloride)

CAS352211-11-1

pharmaceutical raw material

ReferenceSame Category

Kenalog

CAS352431-33-5

pharmaceutical raw material

Referencesame scaffold

Erythromycin EP Impurity L

CAS127955-44-6

pharmaceutical raw material

Referencesame scaffold

Erythromycin f

CAS82230-93-1

pharmaceutical raw material

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Danger
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
Identifiers
IUPAC Name

[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate;dodecyl hydrogen sulfate

InChIKey

AWMFUEJKWXESNL-JZBHMOKNSA-N

SMILES

CCCCCCCCCCCCOS(=O)(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O

Synonyms (52)
  • PELS
  • Erythromycin estolate (USP)
  • Biomicron
  • ERYTHROMYCIN ESTOLATE
  • ERYTHROMYCIN ESTOLATE [MART.]
  • Eriscel
  • Eritroger
  • Eromycin
  • Ery-Toxinal dodecylsulfate
  • Erythromycin (as estolate)
  • Erythromycin Estolate (>85%)
  • Erythromycin estolate CRS
  • Erythromycin estorate
  • Erythromycin estorate (JAN)
  • Erythromycine estolate
  • Erytrarco
  • Estolate, Erythromycin
  • Estomicina
  • Ilosone
  • Ilosone (TN)
  • Lauromicina
  • Lubomycine B
  • Marcoeritrex
  • Neo-erycinum
  • Prospiocine
  • Roxomicina
  • Stellamicina